In episode 108, the rest of the PharmExec editorial staff join Elaine and Miranda to give more insight into the profiles they've written about the eleven members of our 2022 Emerging Pharma Leaders.
Congratulations to our 2022 EPLs: Naveen Bazaj, Gardner Gendron, Aida Habtezion, Matthew J. Hawryluk, Charmaine Lykins, Divya Chadha Manek, Susan Pandya, Matthew R. Price, Quiona Russell, Patricia Torr, and Shetal Vyas!
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.